Diametric Capital’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Diametric Capital’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,778	Closed	-$530K	–	409
2022 Q3	$530K	Buy	+7,778	New	+$429K	0.27%	128

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Diametric Capital's GBT Position: Q4 2022 in Review

Diametric Capital sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 7,778 shares — an estimated $530K sold.

Diametric Capital first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $530K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Diametric Capital reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Diametric Capital sold 7,778 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $530K.
Diametric Capital first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
Diametric Capital's Global Blood Therapeutics, Inc. position peaked at $530K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Diametric Capital's 13F filing for Q4 2022, filed 29 Mar 2023.